Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May-Jun;17(3):371-372.
doi: 10.1097/ADM.0000000000001120. Epub 2023 Jan 17.

Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder

Dale Terasaki  1
Affiliations
Comment

Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder

Dale Terasaki. J Addict Med. 2023 May-Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author reports no conflicts of interest.

Comment in

  • Letter in Reply.
    Gregory C, Chorny Y, McLeod S, Mohindra R. Gregory C, et al. J Addict Med. 2023 May-Jun 01;17(3):372. doi: 10.1097/ADM.0000000000001119. Epub 2023 Jan 17. J Addict Med. 2023. PMID: 37267197 No abstract available.

Comment on

References

    1. Gregory C, Chorny Y, McLeod SL, et al. First-line medications for the outpatient treatment of alcohol use disorder: a systematic review of perceived barriers. J Addict Med . 2022;16(4):e210–e218.
    1. Rohsenow DJ, Colby SM, Monti PM, et al. Predictors of compliance with naltrexone among alcoholics. Alcohol Clin Exp Res . 2000;24(10):1542–1549.
    1. Busch AC, Denduluri M, Glass J, et al. Predischarge injectable versus oral naltrexone to improve postdischarge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study. Alcohol Clin Exp Res . 2017;41(7):1352–1360.
    1. Malone M, McDonald R, Vittitow A, et al. Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON). Contemp Clin Trials . 2019;81:102–109.
    1. Collins SE, Duncan MH, Smart BF, et al. Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence. Subst Abus . 2015;36(1):21–33.